BERTOLI, GLORIA RITA
BERTOLI, GLORIA RITA
Istituto di Bioimmagini e Sistemi Biologici Complessi (IBSBC)
A Novel Strategy for Glioblastoma Treatment by Natural Bioactive Molecules Showed a Highly Effective Anti-Cancer Potential
2024 Giammona, Alessandro; Commisso, Mauro; Bonanomi, Marcella; Remedia, Sofia; Avesani, Linda; Porro, Danilo; Gaglio, Daniela; Bertoli, Gloria; LO DICO, Alessia
Biodiversity and planetary health: a call for integrated action
2024 Cena, H.; Labra, M.; Fraschetti, S.; Sarà, G.; Luna, G. M.; Chiantore, M.; Frati, F.; Rebecchi, L.; Spano, D.; Calfapietra, C.; Pastore, M. C.; Bertoli, G.; Porro, D.; Saggio, I.; Gigli, G.; Basile, M. C.; Coratella, R.; Di Minin, A.; Fiorentino, L.; Carrozza, M. C.; Guzzo, F.; Martellos, S.; Galimberti, A.; Pievani, T.; De Giuseppe, R.
Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways
2024 D'Antona, S.; Porro, D.; Gallivanone, F.; Bertoli, G.
Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study
2024 Bertoli, G.; Fortunato, F.; Cava, C.; Manna, I.; Gallivanone, F.; Labate, A.; Panio, A.; Porro, D.; Gambardella, A.
The biological interplay between air pollutants and miRNAs regulation in cancer
2024 Giammona, A.; Remedia, S.; Porro, D.; Lo Dico, A.; Bertoli, G.
CMA mediates resistance in breast cancer models.
2023 Lo Dico, A; Martelli, C; Corsi, F; Porro, D; Ottobrini, L; Bertoli, G
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models
2023 Rainone, P; Valtorta, S; Villa, C; Todde, S; Cadamuro, M; Bertoli, G; Conconi, D; Lavitrano, M; Moresco, Rm
Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis
2022 Panio, A; Cava, C; D'Antona, S; Bertoli, G; Porro, D
Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction
2022 Dal Santo G,; Frasca M.; Bertoli G.; Castiglioni C.; Cava C.
Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy
2022 Foglieni, C; Lombardi, M; Lazzeroni, D; Zerboni, R; Lazzarini, E; Bertoli, G; Pisano, A; Girolami, F; Andolfo, A; Magagnotti, C; Peretto, G; Sartorio, Cl; Olivotto, I; La Canna, G; Alfieri, O; Rimoldi, Oe; Barile, L; D'Amati, G; Camici, Pg
Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy
2022 Manna, I; Fortunato, F; De Benedittis, S; Sammarra, I; Bertoli, G; Labate, A; Gambardella, A
Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions
2022 Gallivanone, F; Bertoli, G; Porro, D
Secreted miR-153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer
2022 Bertoli, G; Panio, A; Cava, C; Gallivanone, F; Alini, M; Strano, G; Molfino, F; Brioschi, L; Viani, P; Porro, D
Secreted miR‐153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer
2022 Bertoli, G.; Panio, A.; Cava, C.; Gallivanone, F.; Alini, M.; Strano, G.; Molfino, F.; Brioschi, L.; Viani, P.; Porro, D.
Circulating microRNA: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study.
2021 De Benedittis, S.; Fortunato, F.; Cava, C.; Gallivanone, F.; Iaccino, E.; Caligiuri, M. E.; Castiglioni, I.; Bertoli, G.; Manna, I.; Labate, A.; Gambardella, A.
Circulating microRNAs as Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy: A Pilot Study
2021 De Benedittis, Selene; Fortunato, Francesco; Cava, Claudia; Gallivanone, Francesca; Iaccino, Enrico; Eugenia Caligiuri, Maria; Castiglioni, Isabella; Bertoli, Gloria; Manna, Ida; Labate, Angelo; Gambardella, Antonio
Evaluation of Radiotherapy associated with Temozolomide plus Metformin in a GBM immunocompetent microenvironment
2021 Salvatore, D; Valtorta, S; Bertoli, G; Todde, S; Iannone, M; Coliva, A; Toninelli, E; Spinelli, A; Zerbetto, F; Villa, S; Di Muzio, N; Moresco, R
Minor Allele Frequencies and Molecular Pathways Differences for SNPs Associated with Amyotrophic Lateral Sclerosis in Subjects Participating in the UKBB and 1000 Genomes Project
2021 D'Antona, S; Bertoli, G; Castiglioni, I; Cava, C
Plasmatic and myocardial microRNA profiles in patients with Hypertrophic Cardiomyopathy
2021 Lombardi, M; Lazzeroni, D; Benedetti, G; Bertoli, G; Lazarevic, D; Riba, M; De Cobelli, F; Rimoldi, O; D'Amati, G; Olivotto, I; Foglieni, C; Camici, P
Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation
2021 Cava C.; Bertoli G; Castiglioni I.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A Novel Strategy for Glioblastoma Treatment by Natural Bioactive Molecules Showed a Highly Effective Anti-Cancer Potential | 1-gen-2024 | Giammona, Alessandro; Commisso, Mauro; Bonanomi, Marcella; Remedia, Sofia; Avesani, Linda; Porro, Danilo; Gaglio, Daniela; Bertoli, Gloria; LO DICO, Alessia | |
Biodiversity and planetary health: a call for integrated action | 1-gen-2024 | Cena, H.; Labra, M.; Fraschetti, S.; Sarà, G.; Luna, G. M.; Chiantore, M.; Frati, F.; Rebecchi, L.; Spano, D.; Calfapietra, C.; Pastore, M. C.; Bertoli, G.; Porro, D.; Saggio, I.; Gigli, G.; Basile, M. C.; Coratella, R.; Di Minin, A.; Fiorentino, L.; Carrozza, M. C.; Guzzo, F.; Martellos, S.; Galimberti, A.; Pievani, T.; De Giuseppe, R. | |
Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways | 1-gen-2024 | D'Antona, S.; Porro, D.; Gallivanone, F.; Bertoli, G. | |
Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study | 1-gen-2024 | Bertoli, G.; Fortunato, F.; Cava, C.; Manna, I.; Gallivanone, F.; Labate, A.; Panio, A.; Porro, D.; Gambardella, A. | |
The biological interplay between air pollutants and miRNAs regulation in cancer | 1-gen-2024 | Giammona, A.; Remedia, S.; Porro, D.; Lo Dico, A.; Bertoli, G. | |
CMA mediates resistance in breast cancer models. | 1-gen-2023 | Lo Dico, A; Martelli, C; Corsi, F; Porro, D; Ottobrini, L; Bertoli, G | |
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models | 1-gen-2023 | Rainone, P; Valtorta, S; Villa, C; Todde, S; Cadamuro, M; Bertoli, G; Conconi, D; Lavitrano, M; Moresco, Rm | |
Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis | 1-gen-2022 | Panio, A; Cava, C; D'Antona, S; Bertoli, G; Porro, D | |
Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction | 1-gen-2022 | Dal Santo G,; Frasca M.; Bertoli G.; Castiglioni C.; Cava C. | |
Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy | 1-gen-2022 | Foglieni, C; Lombardi, M; Lazzeroni, D; Zerboni, R; Lazzarini, E; Bertoli, G; Pisano, A; Girolami, F; Andolfo, A; Magagnotti, C; Peretto, G; Sartorio, Cl; Olivotto, I; La Canna, G; Alfieri, O; Rimoldi, Oe; Barile, L; D'Amati, G; Camici, Pg | |
Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy | 1-gen-2022 | Manna, I; Fortunato, F; De Benedittis, S; Sammarra, I; Bertoli, G; Labate, A; Gambardella, A | |
Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions | 1-gen-2022 | Gallivanone, F; Bertoli, G; Porro, D | |
Secreted miR-153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer | 1-gen-2022 | Bertoli, G; Panio, A; Cava, C; Gallivanone, F; Alini, M; Strano, G; Molfino, F; Brioschi, L; Viani, P; Porro, D | |
Secreted miR‐153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer | 1-gen-2022 | Bertoli, G.; Panio, A.; Cava, C.; Gallivanone, F.; Alini, M.; Strano, G.; Molfino, F.; Brioschi, L.; Viani, P.; Porro, D. | |
Circulating microRNA: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study. | 1-gen-2021 | De Benedittis, S.; Fortunato, F.; Cava, C.; Gallivanone, F.; Iaccino, E.; Caligiuri, M. E.; Castiglioni, I.; Bertoli, G.; Manna, I.; Labate, A.; Gambardella, A. | |
Circulating microRNAs as Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy: A Pilot Study | 1-gen-2021 | De Benedittis, Selene; Fortunato, Francesco; Cava, Claudia; Gallivanone, Francesca; Iaccino, Enrico; Eugenia Caligiuri, Maria; Castiglioni, Isabella; Bertoli, Gloria; Manna, Ida; Labate, Angelo; Gambardella, Antonio | |
Evaluation of Radiotherapy associated with Temozolomide plus Metformin in a GBM immunocompetent microenvironment | 1-gen-2021 | Salvatore, D; Valtorta, S; Bertoli, G; Todde, S; Iannone, M; Coliva, A; Toninelli, E; Spinelli, A; Zerbetto, F; Villa, S; Di Muzio, N; Moresco, R | |
Minor Allele Frequencies and Molecular Pathways Differences for SNPs Associated with Amyotrophic Lateral Sclerosis in Subjects Participating in the UKBB and 1000 Genomes Project | 1-gen-2021 | D'Antona, S; Bertoli, G; Castiglioni, I; Cava, C | |
Plasmatic and myocardial microRNA profiles in patients with Hypertrophic Cardiomyopathy | 1-gen-2021 | Lombardi, M; Lazzeroni, D; Benedetti, G; Bertoli, G; Lazarevic, D; Riba, M; De Cobelli, F; Rimoldi, O; D'Amati, G; Olivotto, I; Foglieni, C; Camici, P | |
Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation | 1-gen-2021 | Cava C.; Bertoli G; Castiglioni I. |